The Food and Drug Administration advisory panel unanimously recommended the approval of an epilepsy medication found in marijuana. The drug's active ingredient, cannabidiol, is one to the chemical compound found in the cannabis plant , but does not get people high. This will be the first cannabis derived prescription medicine available int he United States.
The drug Epidiolex, is made by GW Pharmaceuticals, a British company. This development underscores that there are medicinal properties in cannabidiol (CBD). GW Pharma had significant results for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Although an increase risk of liver damage was flagged, the FDA thinks it can be managed.